» Authors » Eric P Plaisance

Eric P Plaisance

Explore the profile of Eric P Plaisance including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 59
Citations 928
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Plaisance E
Curr Opin Gastroenterol . 2025 Jan; 41(2):81-86. PMID: 39782299
Purpose Of Review: Metabolic dysfunction-associated steatotic liver disease (MASLD) is present in 25-35% of individuals in the United States. The purpose of this review is to provide the contextual framework...
2.
Plaisance E, Bergeron J, Bolyard M, Hathorne H, Graziano C, Hartzes A, et al.
Nutrients . 2024 Nov; 16(22). PMID: 39599743
Introduction: Cystic fibrosis transmembrane conductance regulator () modulators have greatly improved outcomes in persons with CF (pwCF); however, there is still significant heterogeneity in clinical responses, particularly with regard to...
3.
Ellison K, Smith K, Fernandez J, Plaisance E, Chui T, Hill J, et al.
Obes Sci Pract . 2024 Nov; 10(6):e70022. PMID: 39529897
Objective: While weight status and clinical laboratory measures are important in assessing obesity-related disease severity and chronic disease risk, including a broader range of emotional, psychosocial, and behavioral factors would...
4.
Ogbonna H, Roberts Z, Godwin N, Muri P, Turbitt W, Swalley Z, et al.
Cancers (Basel) . 2024 Oct; 16(19). PMID: 39410010
Background/objectives: Ketone esters (KEs) exhibit promise as anti-cancer agents but their impact on spontaneous metastases remains poorly understood. Although consumption of a ketogenic diet (KD) that is low in carbohydrates...
5.
Deemer S, Roberts B, Smith D, Plaisance E, Philp A
Am J Physiol Cell Physiol . 2024 May; 327(1):C140-C150. PMID: 38766768
Identifying effective treatment(s) for sarcopenia and sarcopenic obesity is of paramount importance as the global population advances in age and obesity continues to be a worldwide concern. Evidence has shown...
6.
Cannon S, Mintz J, Roberts B, Rushing K, Jenkins G, Fisher G, et al.
Int J Exerc Sci . 2024 Apr; 17(4):172-182. PMID: 38665851
Methods: Twenty-six student Cadets of the ROTC at the University of Alabama at Birmingham (UAB) program participated in the study. Over an 8-month period, the ROTC Cadets trained on campus...
7.
Bolyard M, Graziano C, Fontaine K, Sayer R, Fisher G, Plaisance E
Nutrients . 2023 Dec; 15(23). PMID: 38068734
Exogenous ketone ester and ketone ester mixed with ketone free acid formulations are rapidly entering the commercial marketspace. Short-term animal and human studies using these products suggest significant potential for...
8.
Rushing K, Bolyard M, Kelty T, Wieschhaus N, Pavela G, Rector R, et al.
Front Physiol . 2023 Apr; 14:1165224. PMID: 37113697
The ketone diester, R,S-1,3-butanediol diacetoacetate (BD-AcAc), attenuates the accretion of adiposity and reduces hepatic steatosis in high-fat diet-induced obese mice when carbohydrate energy is removed from the diet to accommodate...
9.
Roberts B, Deemer S, Smith Jr D, Mobley J, Musi N, Plaisance E
Front Nutr . 2022 Dec; 9:1041026. PMID: 36458175
Exogenous ketone ester supplementation provides a means to increase circulating ketone concentrations without the dietary challenges imposed by ketogenic diets. Our group has shown that oral R,S-1,3, butanediol diacetoacetate (BD-AcAc)...
10.
Lane J, Brown N, Williams S, Plaisance E, Fontaine K
Nutrients . 2021 Oct; 13(10). PMID: 34684564
Despite remarkable improvements in screening, diagnosis, and targeted therapies, cancer remains the second leading cause of death in the United States. It is increasingly clear that diet and lifestyle practices...